#2154155
FLUIFEANAICÉAT
FLUFENACET
Filter results
Collections
32 results in 18 documents
#2183884
Fluifeanaicéat (ISO) (CAS RN 142459-58-3) ag a bhfuil íonacht 95 % nó níos mó de réir meáchain
Flufenacet (ISO) (CAS RN 142459-58-3) with a purity by weight of 95 % or more
#2607913
Fluifeanaicéat (ISO) (CAS RN 142459-58-3) ag a bhfuil íonacht 95 % nó níos mó de réir meáchain
Flufenacet (ISO) (CAS RN 142459-58-3) with a purity by weight of 95 % or more
#3145955
Fluifeanaicéat (ISO) (CAS RN 142459-58-3) ag a bhfuil íonacht 95 % nó níos mó de réir meáchain
Flufenacet (ISO) (CAS RN 142459-58-3) with a purity by weight of 95 % or more
#2125157
sa séú colún, dul in éag an fhormheasa, de ró 65, Fluifeanaicéat, cuirtear “31 Deireadh Fómhair 2022” in ionad an dáta;
in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2022’;
#2517577
sa séú colún, dul in éag an fhormheasa, de ró 65, Fluifeanaicéat, cuirtear “31 Deireadh Fómhair 2023” in ionad an dáta;
in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘31 October 2023’;
#2961925
(2) sa séú colún, dul in éag an fhormheasa, de ró 65, Fluifeanaicéat, cuirtear ‘15 Meitheamh 2025’ in ionad an dáta;
(2) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by ‘15 June 2025’;
#2125120
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eatafeanprocs, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, sulfar, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
#2125131
Thairis sin, is gá síneadh a chur leis an tréimhse formheasa i gcás na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, clóifeintisín, clómasón, daimínisíd, feanocsapróp-P, fluidhé-ocsainil, fluifeanaicéat, leanacail, trífhlusulfúrón agus tríteasulfúrón chun an t-am is gá a chur ar fáil chun measúnú a dhéanamh i ndáil le hairíonna suaite inchríneach na substaintí gníomhacha sin i gcomhréir leis an nós imeachta a leagtar amach in Airteagal 13 agus Airteagal 14 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012.
In addition, an extension of the approval period is required for the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, clofentezine, clomazone, daminozide, fenoxaprop-P, fludioxonil, flufenacet, lenacil, triflusulfuron and tritosulfuron to provide the time necessary to carry out an assessment relating to endocrine disrupting properties of those active substances in accordance with the procedure set out in Articles 13 and 14 of Implementing Regulation (EU) No 844/2012.
#2125147
Rialachán Cur Chun Feidhme (AE) 2020/1511 ón gCoimisiún an 16 Deireadh Fómhair 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aimídeasulfúrón, défheanocs, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, pioclóram, prósulfacarb, sulfar, trífhlusulfúrón agus tríteasulfúrón (IO L 344, 19.10.2020, lch. 18).
Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (OJ L 344, 19.10.2020, p. 18).
#2125193
Le Rialachán Cur Chun Feidhme (AE) 2020/1511 ón gCoimisiún cuireadh síneadh le tréimhsí formheasa na substaintí gníomhacha clóratolúrón, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, MCPA, MCPB agus prósulfacarb go dtí an 31 Deireadh Fómhair 2021, cuireadh síneadh le tréimhsí formheasa na substainte gníomhaí tríteasulfúrón go dtí 30 Samhain 2021 agus cuireadh síneadh le tréimhsí formheasa na substaintí gníomhacha aimídeasulfúrón, défheanocs, clóifeintisín, díceamba, défheanaconasól, défhluifeineacan, feanocsapróp-P, feanpróipidín, leanacail, niceasulfúrón, olaí pairifín, pioclóram, sulfar agus trífhlusulfúrón go dtí 31 Nollaig 2021.
Commission Implementing Regulation (EU) 2020/1511 extended the approval period of the active substances chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, indoxacarb, MCPA, MCPB, and prosulfocarb until 31 October 2021, of the active substance tritosulfuron until 30 November 2021 and of the active substances amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, paraffin oils, picloram, sulphur and triflusulfuron until 31 December 2021.
#2160326
Rialachán Cur Chun Feidhme (AE) 2021/1449 ón gCoimisiún an 3 Meán Fómhair 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eatafeanprocs, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, sulfar, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 313, 6.9.2021, lch. 20).
Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 313, 6.9.2021, p. 20).
#2162351
Rialachán Cur Chun Feidhme (AE) 2021/1449 ón gCoimisiún an 3 Meán Fómhair 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eatafeanprocs, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, sulfar, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 313, 6.9.2021, lch. 20).
Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 313, 6.9.2021, p. 20).
#2377694
Tá Rialachán Cur Chun Feidhme (AE) 2021/1449 ón gCoimisiún an 3 Meán Fómhair 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasta na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail an salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défeanaconasól, défhluifeineacan, démhéiteaclór, eatafeanprocs, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, própacuiseafop, prósulfacarb, cuisileafop-P-etil, cuisileafop-P-teafuiril, sulfar, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron is to be incorporated into the EEA Agreement.
#2383795
Rialachán Cur Chun Feidhme (AE) 2018/1262 ón gCoimisiún an 20 Meán Fómhair 2018 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh ama a chur le tréimhsí formheasa na substaintí gníomhacha 1-meitilcioglapróipéin, béite-ciafluaitrin, clóratailinil, clóratolúrón, clómasón, cipirmeitrin, daimínisíd deiltemheitrin, démheitéanaimíd-p, dé- úrón, fluidhé-ocsainil, fluifeanaicéat, flúrtamón, foistiasáit, iondocsacarb, MCPA, MCPB, prósulfacarb, tiafanáit-meitil agus tríbheanúrón, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2018/1262 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-methylcyclopropene, beta-cyfluthrin, chlorothalonil, chlorotoluron, clomazone, cypermethrin, daminozide, deltamethrin, dimethenamid-p, diuron, fludioxonil, flufenacet, flurtamone, fosthiazate, indoxacarb, MCPA, MCPB, prosulfocarb, thiophanate-methyl and tribenuron is to be incorporated into the EEA Agreement.
#2517535
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, beansulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eisfeanvailéaráit, eatafeanprocs, feanocsapróp-P, feanpróipidín, feinpiorasaimín, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, próiheicseaidé-ón, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam, sulfar, teabúifeinpiorad, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
#2517549
Thairis sin, is gá síneadh a chur leis an tréimhse formheasa i gcás na substaintí gníomhacha aimídeasulfúrón, clómasón, daimínisíd, défheanaconasól, défhluifeineacan, feanocsapróp-P, fluidhé-ocsainil, fluifeanaicéat, agus tríteasulfúrón chun an t-am is gá a chur ar fáil chun measúnú a dhéanamh i ndáil le hairíonna suaite inchríneach na substaintí gníomhacha sin i gcomhréir leis an nós imeachta a leagtar amach in Airteagail 13 agus 14 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012.
In addition, an extension of the approval period is required for the active substances amidosulfuron, clomazone, daminozide, difenoconazole, diflufenican, fenoxaprop-P, fludioxonil, flufenacet, and tritosulfuron to provide the time necessary to carry out an assessment relating to endocrine disrupting properties of those active substances in accordance with the procedure set out in Articles 13 and 14 of Implementing Regulation (EU) No 844/2012.
#2517565
Rialachán Cur Chun Feidhme (AE) 2021/1449 ón gCoimisiún an 3 Meán Fómhair 2021 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eatafeanprocs, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, sulfar, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 313, 6.9.2021, lch. 20).
Commission Implementing Regulation (EU) 2021/1449 of 3 September 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sulphur, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 313, 6.9.2021, p. 20).
#2517623
Le Rialachán Cur Chun Feidhme (AE) 2021/1449 ón gCoimisiún, cuireadh síneadh le tréimhsí formheasa na substaintí gníomhacha clóratolúrón, clómasón, daimínisíd, deiltemheitrin, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, MCPA, MCPB agus prósulfacarb go dtí an 31 Deireadh Fómhair 2022, cuireadh síneadh le tréimhsí formheasa na substaintí gníomhacha clóirmeacuat, própacuiseafop, cuisileafop-P-eitil, cuisileafop-P-teafuiril, tríteasulfúrón go dtí 30 Samhain 2022 agus cuireadh síneadh le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól, 8-hiodrocsacuineoilín, aimídeasulfúrón, défheanocs, clóifeintisín, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eatafeanprocs, feanocsapróp-P, feanpróipidín, leanacail, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, sulfar, teitreaconasól, trí-alláit agus trífhlusulfúrón go dtí an 31 Nollaig 2022.
Commission Implementing Regulation (EU) 2021/1449 extended the approval period of the active substances chlorotoluron, clomazone, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, MCPA, MCPB and prosulfocarb until 31 October 2022, of the active substances chlormequat, propaquizafop, quizalofop-P-ethyl, quizalofop-P-tefuryl and tritosulfuron until 30 November 2022 and of the active substances 2-phenylphenol, 8-hydroxyquinoline, amidosulfuron, bifenox, clofentezine, dicamba, difenoconazole, diflufenican, dimethachlor, etofenprox, fenoxaprop-P, fenpropidin, lenacil, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, sulphur, tetraconazole, tri-allate and triflusulfuron until 31 December 2022.
#2657488
Rialachán Cur Chun Feidhme (AE) 2019/1589 ón gCoimisiún an 26 Meán Fómhair 2019 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aimídeasulfúrón, béite-ciafluitrin, défheanocs, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluibeansúrón, défhluifeineacan, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, pioclóram, prósulfacarb, pireaprocsaifein, tiafanáit-meitil, trífhlusulfúrón agus tríteasulfúrón, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2019/1589 of 26 September 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron is to be incorporated into the EEA Agreement.
#2892916
Rialachán Cur Chun Feidhme (AE) 2022/1480 ón gCoimisiún an 7 Meán Fómhair 2022 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, beansulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eisfeanvailéaráit, eatafeanprocs, feanocsapróp-P, feanpróipidín, feinpiorasaimín, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, próiheicseaidé-ón, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam, sulfar, teabúifeinpiorad, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron is to be incorporated into the EEA Agreement.
#2961873
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beansulfúrón, clóirmeacuat, clóratolúrón, clómasón, daimínisíd, deiltemheitrin, eoigeanól, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, géiréiniól, MCPA, MCPB, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam, fluairíd sulfairile, teabúifeinpiorad, tíomól agus tríteasulfúrón
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, eugenol, fludioxonil, flufenacet, flumetralin, fosthiazate, geraniol, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad, thymol, and tritosulfuron
#2961881
(2) Na substaintí gníomhacha beansulfúrón, clóirmeacuat, clóratolúrón, clómasón, daimínisíd, deiltemheitrin, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, MCPA, MCPB, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam, fluairíd sulfairile, teabúifeinpiorad, agus tríteasulfúrón, liostaítear iad i gCuid A den Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011.
(2) The active substances bensulfuron, chlormequat, chlorotoluron, clomazone, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, MCPA, MCPB, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulfuryl fluoride, tebufenpyrad and tritosulfuron are listed in Part A of the Annex to Implementing Regulation (EU) No 540/2011.
#2961883
(3) Le Rialachán Cur Chun Feidhme (AE) 2022/1480 ón gCoimisiún, cuireadh síneadh le tréimhse formheasa na substaintí beansulfúrón, clóratolúrón, clómasón, daimínisíd, deiltemheitrin, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, MCPA, MCPB, prósulfacarb, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam agus teabúifeinpiorad go dtí an 31 Deireadh Fómhair 2023, le tréimhse formheasa na substaintí gníomhacha clóirmeacuat, própacuiseafop, cuisileafop-P-eitil, cuisileafop-P-teafuiril, agus tríteasulfúrón go dtí an 30 Samhain 2023 agus le tréimhse formheasa na substainte gníomhaí fluimeitrilin go dtí an 11 Nollaig 2023.
(3) Commission Implementing Regulation (EU) 2022/1480 extended the approval period of the active substances bensulfuron, chlorotoluron, clomazone, daminozide, deltamethrin, fludioxonil, flufenacet, fosthiazate, MCPA, MCPB, prosulfocarb, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, and tebufenpyrad until 31 October 2023, of the active substances chlormequat, propaquizafop, quizalofop-P-ethyl, quizalofop-P-tefuryl and tritosulfuron until 30 November 2023 and of the active substance flumetralin until 11 December 2023.
#2961893
(11) Maidir leis na substaintí gníomhacha clómasón, daimínisíd, fluidhé-ocsainil, fluifeanaicéat agus tríteasulfúrón, d’iarr an tÚdarás faisnéis bhreise de bhun Airteagal 13(3a), an chéad fhomhír, de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 chun measúnú a dhéanamh ar na critéir formheasa a leagtar amach i bpointe 3.6.5 agus i bpointe 3.8.2 d’Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 1107/2009 agus chuir na hiarratasóirí isteach í laistigh den tréimhse a shocraigh an tÚdarás.
(11) For the active substances clomazone, daminozide, fludioxonil, flufenacet and tritosulfuron, additional information for the purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, was requested by the Authority pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012 and was submitted by the applicants within the period set by the Authority.
#2961898
(15) Ós rud é gur iarr an tÚdarás faisnéis bhreise chun measúnú a dhéanamh ar na critéir formheasa a leagtar amach i bpointe 3.6.5 agus i bpointe 3.8.2 d’Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 1107/2009, ba cheart 22.5 mí de shíneadh a shocrú i gcás na substainte ghníomhaí daimínisíd, agus ós rud é gur gá breis ama chun meastóireacht a dhéanamh, ba cheart 19.5 mí de shíneadh a shocrú i gcás na substaintí gníomhacha clómasón, fluidhé-ocsainil, fluifeanaicéat agus tríteasulfúrón.
(15) As the Authority requested additional information for the purposes of assessment of the approval criteria set out in point 3.6.5 and point 3.8.2 of Annex II to Regulation (EC) No 1107/2009, the duration of the extension for the active substance daminozide should be set at twenty-two months and a half and, as additional time is needed for its evaluation, the duration of the extension for the active substances clomazone, fludioxonil, flufenacet and tritosulfuron should be set at nineteen months and a half.
#2961915
[4] Rialachán Cur Chun Feidhme (AE) 2022/1480 ón gCoimisiún an 7 Meán Fómhair 2022 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, beansulfúrón, défheanocs, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défhluifeineacan, démhéiteaclór, eisfeanvailéaráit, eatafeanprocs, feanocsapróp-P, feanpróipidín, feinpiorasaimín, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, próiheicseaidé-ón, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam, sulfar, teabúifeinpiorad, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 233, 8.9.2022, lch. 43).
[4] Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 233, 8.9.2022, p. 43).
#3028966
Rialachán Cur Chun Feidhme (AE) 2022/1480 ón gCoimisiún an 7 Meán Fómhair 2022 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 5-nítreaguaidheacóláit sóidiam, 8-hiodrocsacuineoilín, aimídeasulfúrón, beansulfúrón, clóifeintisín, clóirmeacuat, clómasón, clóratolúrón, cuisileafop-P-eitil, cuisileafop-P-teafuiril, daimínisíd, défheanaconasól, défheanocs, défhluifeineacan, deiltemheitrin, démhéiteaclór, díceamba, eatafeanprocs, eisfeanvailéaráit, feanocsapróp-P, feanpróipidín, feinpiorasaimín, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, leanacail, MCPA, MCPB, niceasulfúrón, ola phairifín, olaí pairifín, o-nítrifeanóláit sóidiam, peanconasól, pioclóram, p-nítrifeanóláit sóidiam, próiheicseaidé-ón, própacuiseafop, prósulfacarb, sulfar, teabúifeinpiorad, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 233, 8.9.2022, lch. 43).
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 233, 8.9.2022, p. 43).
#3033858
Rialachán Cur Chun Feidhme (AE) 2022/1480 ón gCoimisiún an 7 Meán Fómhair 2022 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 5-nítreaguaidheacóláit sóidiam, 8-hiodrocsacuineoilín, aimídeasulfúrón, beansulfúrón, clóifeintisín, clóirmeacuat, clómasón, clóratolúrón, cuisileafop-P-eitil, cuisileafop-P-teafuiril, daimínisíd, défheanaconasól, défheanocs, défhluifeineacan, deiltemheitrin, démhéiteaclór, díceamba, eatafeanprocs, eisfeanvailéaráit, feanocsapróp-P, feanpróipidín, feinpiorasaimín, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, leanacail, MCPA, MCPB, niceasulfúrón, ola phairifín, olaí pairifín, o-nítrifeanóláit sóidiam, peanconasól, pioclóram, p-nítrifeanóláit sóidiam, próiheicseaidé-ón, própacuiseafop, prósulfacarb, sulfar, teabúifeinpiorad, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 233, 8.9.2022, lch. 43).
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 233, 8.9.2022, p. 43).
#3037555
Rialachán Cur Chun Feidhme (AE) 2022/1480 ón gCoimisiún an 7 Meán Fómhair 2022 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha 2-feinilfeanól (lena n-áirítear a shalainn amhail salann sóidiam), 8-hiodrocsacuineoilín, aimídeasulfúrón, beansulfúrón, clóirmeacuat, clóratolúrón, clóifeintisín, clómasón, daimínisíd, deiltemheitrin, díceamba, défheanaconasól, défheanocs, défhluifeineacan, démhéiteaclór, eatafeanprocs, eisfeanvailéaráit, feanocsapróp-P, feanpróipidín, feinpiorasaimín, fluidhé-ocsainil, fluifeanaicéat, fluimeitrilin, foistiasáit, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, ola phairifín, peanconasól, pioclóram, próiheicseaidé-ón, própacuiseafop, prósulfacarb, cuisileafop-P-eitil, cuisileafop-P-teafuiril, 5-nítreaguaidheacóláit sóidiam, o-nítrifeanóláit sóidiam, p-nítrifeanóláit sóidiam, sulfar, teabúifeinpiorad, teitreaconasól, trí-alláit, trífhlusulfúrón agus tríteasulfúrón (IO L 233, 8.9.2022, lch. 43).
Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron (OJ L 233, 8.9.2022, p. 43).
#3088363
Rialachán Cur Chun Feidhme (AE) 2020/1511 ón gCoimisiún an 16 Deireadh Fómhair 2020 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha aimídeasulfúrón, cipirmeitrin, clóifeintisín, clómasón, clóratolúrón, daimínisíd, deiltemheitrin, défheanaconasól, défheanocs, défhluifeineacan, díceamba, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, pioclóram, prósulfacarb, sulfar, trífhlusulfúrón agus tríteasulfúrón, tá sé le hionchorprú i gComhaontú LEE.
Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron is to be incorporated into the EEA Agreement.
#2627652
Rún ó Pharlaimint na hEorpa an 26 Samhain 2020 maidir le Rialachán Cur Chun Feidhme (AE) 2020/1511 an 16 Deireadh Fómhair 2020 lena leasaítear Rialachán (AE) Uimh. 540/2011 ó Pharlaimint na hEorpa agus ón gComhairle maidir le síneadh a chur le tréimhsí formheasta na substaintí gníomhacha aimídeasulfúrón, défheanocs, clóratolúrón, clóifeintisín, clómasón, cipirmeitrin, daimínisíd, deiltemheitrin, díceamba, défeanaconasól, défhluifeineacan, feanocsapróp-P, feanpróipidín, fluidhé-ocsainil, fluifeanaicéat, foistiasáit, iondocsacarb, leanacail, MCPA, MCPB, niceasulfúrón, olaí pairifín, pioclóram, prósulfacarb, sulfar, trífhlusulfúrón, tríteasulfúrón (IO C 425, 20.10.2021, lch. 87) agus Rún ó Pharlaimint na hEorpa an 10 Meitheamh 2021 maidir le Rialachán Cur Chun Feidhme (AE) 2021/745 an 6 Bealtaine 2021 ón gCoimisiún lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha sulfáit amóiniam alúmanaim, sileacáit alúmanaim, beaflubútaimíd, beintiavalacarb, défheineasáit, boscailid, carbónáit chailciam, captán, dé-ocsaíd charbóin, ciamocsainil, démheatomorf, eiteafón, úsc as crann tae, famocsadón, iarmhair ó dhriogadh saille, aigéid shailleacha C7 go C20, flumocsaisín, fluocsastróibin, fluraclóradón, foilpéad, foirmeiteanáit, aigéad gibriline, gibriliní, heipteamalocsalaglúcan, próitéiní hidrealaithe, sulfáit iarainn, meatasaclór, meitríbhúisín, milbimeictin, tréithchineál 251 Paecilomyces lilacinus, feinmeideafam, foismeit, pirimeafos-meitil, olaí planda/ola ráibe, hidrigincharbónáit photaisiam, própamacarb, próitiaconasól, gaineamh grianchloiche, ola éisc, éarthaigh bholaidh de thionscnamh ainmhí nó planda/saill caoireola, S-meitileaclór, fearamóin léipidipteire Slabhra Dhírigh, teabúconasól agus úiré (IO C 67, 8.2.2022, lch. 75).
European Parliament resolution of 26 November 2020 on Commission Implementing Regulation (EU) 2020/1511 of 16 October 2020 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, picloram, prosulfocarb, sulphur, triflusulfuron and tritosulfuron (OJ C 425, 20.10.2021, p. 87) and European Parliament resolution of 10 June 2021 on Commission Implementing Regulation (EU) 2021/745 of 6 May 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances aluminium ammonium sulphate, aluminium silicate, beflubutamid, benthiavalicarb, bifenazate, boscalid, calcium carbonate, captan, carbon dioxide, cymoxanil, dimethomorph, ethephon, extract from tea tree, famoxadone, fat distillation residues, fatty acids C7 to C20, flumioxazine, fluoxastrobin, flurochloridone, folpet, formetanate, gibberellic acid, gibberellins, heptamaloxyloglucan, hydrolysed proteins, iron sulphate, metazachlor, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, plant oils/rape seed oil, potassium hydrogen carbonate, propamocarb, prothioconazole, quartz sand, fish oil, repellents by smell of animal or plant origin/sheep fat, S-metolachlor, Straight Chain Lepidopteran Pheromones, tebuconazole and urea (OJ C 67, 8.2.2022, p. 75).